Prostate-Specific Antigen Screening for High-risk Insured Men Act requires coverage for prostate cancer screenings without cost-sharing for high-risk.
The Prostate-Specific Antigen Screening for High-risk Insured Men Act amends the Public Health Service Act to mandate group health plans and health insurance issuers to cover prostate cancer screenings without cost-sharing for men at high risk, including African-American men and those with a family history of prostate cancer. The Act aims to improve early detection and survival rates by minimizing barriers to screening. The changes apply to plan years beginning on or after January 1, 2025.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.